Revenue
0 Unit12
2016-09-30 · Unit12
Fundies. English
TETRALOGIC PHARMACEUTICALS CORP
EDGAR14 filing records in this dataset, filed from 2013-10-18 to 2016-11-03. Reported financial figures are available; chart coverage varies by period.
Latest quarter
- Cash and cash equivalents
- 5.89 million Unit12 Source
Exact value
5885474 Unit12
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 24.8 million Unit1 Source
Exact value
24769083 Unit1
Reported share-count change
0.00% · 0 Unit1
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Capital expenditure
186 thousand Unit12
2014-10-01 – 2015-09-30
Exact inputs and evidence
- Capital expenditure: 514855 Unit12 · 2014-01-01 – 2014-12-31 Source
- Capital expenditure: 405179 Unit12 · 2014-01-01 – 2014-09-30 Source
- Capital expenditure: 34488 Unit12 · 2015-01-01 – 2015-03-31 Source
- Capital expenditure: 50474 Unit12 · 2015-01-01 – 2015-06-30 Source
- Capital expenditure: 34488 Unit12 · 2015-01-01 – 2015-03-31 Source
- Capital expenditure: 76666 Unit12 · 2015-01-01 – 2015-09-30 Source
- Capital expenditure: 50474 Unit12 · 2015-01-01 – 2015-06-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2016-11-03.
Financial data available through: 2015-12-31.
Coverage by financial measure
- Revenue: 1 of 11 periods available· newest 2015-12-31
- Operating income: 2 of 11 periods available· newest 2015-12-31
- Net income: 2 of 11 periods available· newest 2015-12-31
- Operating cash flow: 2 of 11 periods available· newest 2015-12-31
- Capital expenditure: 2 of 11 periods available· newest 2015-12-31
- Total assets: Multiple units; comparison withheld· newest 2015-12-31
- Total liabilities: Multiple units; comparison withheld· newest 2015-12-31
- Current assets: Multiple units; comparison withheld· newest 2015-12-31
- Current liabilities: Multiple units; comparison withheld· newest 2015-12-31
- Cash and cash equivalents: Multiple units; comparison withheld· newest 2015-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 1 of 11 periods available· newest 2015-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−Unit13 13.77 millionPrior period
−Unit13 35.96 million
–
Current period
−Unit13 49.72 million
–
Exact inputs and evidence
-49724054 − -35958979 = -13765075 Unit13
-35958979 Unit13 · 2014-01-01 – 2014-12-31
Inspect prior input Prior source-49724054 Unit13 · 2015-01-01 – 2015-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−Unit13 2.52 millionPrior period
−Unit13 32.37 million
–
Current period
−Unit13 34.89 million
–
Exact inputs and evidence
-34889395 − -32366174 = -2523221 Unit13
-32366174 Unit13 · 2014-01-01 – 2014-12-31
Inspect prior input Prior source-34889395 Unit13 · 2015-01-01 – 2015-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-85%Prior period
Unit13 514,855
–
Current period
Unit13 77,332
–
Exact inputs and evidence
77332 − 514855 = -437523 Unit13
514855 Unit13 · 2014-01-01 – 2014-12-31
Inspect prior input Prior source77332 Unit13 · 2015-01-01 – 2015-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2015 2015-01-01 – 2015-12-31
- Revenue Unit13 0
- Operating costs Derived Unit13 44.99 million
- Operating income −Unit13 44.99 million
- Tax, interest and other Derived Unit13 4.73 million
- Net income −Unit13 49.72 million
Cash
- Operating cash flow −Unit13 34.89 million
- Capital expenditure Unit13 77,332
- Free cash flow Derived −Unit13 34.97 million
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2015 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | 0 | 44991026 Derived | -44991026 | 4733028 Derived | -49724054 | -34966727 Derived | Source
|
Amounts are exact, in Unit13.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Unit13 0 2015
Values and sources
| Period | Series | Value(Unit13) | Source evidence |
|---|---|---|---|
| 2015 | Revenue | 0 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Year over year | No prior comparable period |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Operating margin | Not reported |
|
| 2015 | Net margin | Not reported |
|
| 2015 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
Unit13 -34.9M 2015
Values and sources
| Period | Series | Value(Unit13) | Source evidence |
|---|---|---|---|
| 2015 | Operating cash flow | -34889395 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Unit13 -35M 2015
Values and sources
| Period | Series | Value(Unit13) | Source evidence |
|---|---|---|---|
| 2015 | Free cash flow | -34966727 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015-12-31 | Liabilities / assets | Not reported | No source recorded |
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015-12-31 | Current assets / current liabilities | Not reported | No source recorded |
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2014 2014-01-01 – 2014-12-31 | −Unit13 35.96 million Exact valueExact value: -35958979 Unit13 Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit13 32.37 million Exact valueExact value: -32366174 Unit13 Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unit13 514,855 Exact valueExact value: 514855 Unit13 Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit13 32.88 million Calculation and evidence-32366174 − 514855 Unit13 Exact free cash flow: -32881029 Unit13
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2015 2015-01-01 – 2015-12-31 | −Unit13 49.72 million Exact valueExact value: -49724054 Unit13 Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit13 34.89 million Exact valueExact value: -34889395 Unit13 Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unit13 77,332 Exact valueExact value: 77332 Unit13 Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit13 34.97 million Calculation and evidence-34889395 − 77332 Unit13 Exact free cash flow: -34966727 Unit13
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
14 filings · 814 latest values · 814 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001361248, 1361248, edgar:1361248
Also known as TETRALOGIC PHARMACEUTICALS CORP, TETRALOGIC PHARMACEUTICALS Corp